Recombinant human anti-RANKL antibody(Ampo Biotechnology)

重组抗RANKL全人单克隆抗体（广东安普泽）

Report date: 2023/03/05 16:38:20

Base Information

Drug NameRecombinant human anti-RANKL antibody(Ampo Biotechnology)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionTumor necrosis factor ligand superfamily member 11 inhibitors
TargetsTumor necrosis factor ligand superfamily member 11
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesAmpo Biotechnology Inc
China Registration ClassN/A

Develop Information

Active CompaniesAmpo Biotechnology Inc
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A